Display options
Cite
Jain S, Dhir V. Riociguat in systemic sclerosis: a potential for disease modification. Ann Rheum Dis. 2020;doi: 10.1136/annrheumdis-2020-218180.
Jain, S., & Dhir, V. (2020). Riociguat in systemic sclerosis: a potential for disease modification. Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2020-218180
Jain, Siddharth, and Dhir, Varun. "Riociguat in systemic sclerosis: a potential for disease modification." Annals of the rheumatic diseases vol. (2020). doi: https://doi.org/10.1136/annrheumdis-2020-218180
Jain S, Dhir V. Riociguat in systemic sclerosis: a potential for disease modification. Ann Rheum Dis. 2020 Jul 15; doi: 10.1136/annrheumdis-2020-218180. Epub 2020 Jul 15. PMID: 32669302.
Copy Download .nbib Format: NLM
Share it on

Ann Rheum Dis. 2020 Jul 15; doi: 10.1136/annrheumdis-2020-218180. Epub 2020 Jul 15.

Riociguat in systemic sclerosis: a potential for disease modification.

Annals of the rheumatic diseases

Siddharth Jain, Varun Dhir

Affiliations

  1. Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  2. Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India [email protected].

PMID: 32669302 DOI: 10.1136/annrheumdis-2020-218180

[No abstract available.]

Keywords: antirheumatic agents; autoimmune diseases; scleroderma, systemic

Conflict of interest statement

Competing interests: None declared.

Publication Types